Li, J., Jiang, L., Ma, Q., Zhang, Z., Zheng, S., Qiu, J., Pang, Y., Wang, J. (2025). Evodiamine inhibits programmed cell death ligand 1 expression via the PI3K/AKT signaling pathway to regulate antitumor immunity in melanoma. Scientific Reports. https://doi.org/10.1038/s41598-025-91137-2